BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31485913)

  • 21. Updated EORTC QLQ-C30 general population norm data for Germany.
    Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
    Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normative data of the EORTC QLQ-C30 for the German population: a population-based survey.
    Waldmann A; Schubert D; Katalinic A
    PLoS One; 2013; 8(9):e74149. PubMed ID: 24058523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
    King MT; Costa DSJ; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
    Qual Life Res; 2016 Oct; 25(10):2683. PubMed ID: 27060088
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30.
    Lundy JJ; Coons SJ; Aaronson NK
    Patient; 2015 Apr; 8(2):165-70. PubMed ID: 24958466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
    Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
    Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing the measurement equivalence of paper and interactive voice response system versions of the EORTC QLQ-C30.
    Lundy JJ; Coons SJ; Aaronson NK
    Qual Life Res; 2014 Feb; 23(1):229-37. PubMed ID: 23765449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatigue in the general population: German normative values of the EORTC QLQ-FA12.
    Hinz A; Weis J; Brähler E; Mehnert A
    Qual Life Res; 2018 Oct; 27(10):2681-2689. PubMed ID: 29909484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.
    Bulamu NB; Chen G; Ratcliffe J; Schloite A; Bright T; Watson DI
    World J Surg; 2019 Jun; 43(6):1554-1562. PubMed ID: 30719557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
    Pilz MJ; Loth FLC; Nolte S; Thurner AMM; Gamper EM; Anota A; Liegl G; Giesinger JM;
    J Patient Rep Outcomes; 2024 May; 8(1):48. PubMed ID: 38695992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
    Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population.
    Young T; Velikova G; Liegl G; Rose M; Nolte S;
    Eur J Cancer; 2024 Jun; 204():113927. PubMed ID: 38429166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.